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ABSTRACT
Background: Light to moderate alcohol intake lowers the
risk of cardiovascular mortality, but whether this
protective effect can be attributed to a specific type of
beverage remains unclear. Moreover, little is known about
the effects of long-term alcohol intake on life expectancy.
Methods: The impact of long-term alcohol intake and types
of alcoholic beverages consumed on cardiovascular mortality
and life expectancy at age 50 was investigated in the
Zutphen Study, a cohort of 1373 men born between 1900
and 1920 and examined repeatedly between 1960 and
2000. Hazard ratios (HRs) for total alcohol intake and alcohol
from wine, beer and spirits were obtained from time-
dependent Cox regression models. Life expectancy at age 50
was calculated from areas under survival curves.
Results: Long-term light alcohol intake, that is (20 g
per day, compared with no alcohol, was strongly and
inversely associated with cerebrovascular (HR 0.43, 95%
CI 0.26 to 0.70), total cardiovascular (HR 0.70, 95% CI
0.55 to 0.89) and all-cause mortality (HR 0.75, 95% CI
0.63 to 0.91). Independent of total alcohol intake, long-
term wine consumption of, on average, less than half a
glass per day was strongly and inversely associated with
coronary heart disease (HR 0.61, 95% CI 0.41 to 0.89),
total cardiovascular (HR 0.68, 95% CI 0.53 to 0.86) and
all-cause mortality (HR 0.73, 95% CI 0.62 to 0.87). These
results could not be explained by differences in socio-
economic status. Life expectancy was about 5 years
longer in men who consumed wine compared with those
who did not use alcoholic beverages.
Conclusion: Long-term light alcohol intake lowered
cardiovascular and all-cause mortality risk and increased
life expectancy. Light wine consumption was associated
with 5 years longer life expectancy; however, more
studies are needed to verify this result.
Many studies have demonstrated a U- or J-shaped
relationship between alcohol intake and all-cause
mortality. This association can be explained by a
lower risk of cardiovascular disease (CVD) mortal-
ity in light to moderate drinkers.1–4 The protective
effect of light to moderate alcohol intake may be
due to an increase in high-density lipoprotein
(HDL) cholesterol and prevention of blood clotting
and reduction in platelet aggregation.5 6 Red wine
consumption may have an additional health
benefit because of its polyphenolic compounds7 8
that interfere with the initiation, progression and
rupture of atherosclerotic plaques9 and improve
endothelial function.10 11 Although some epidemio-
logical studies showed beneficial effects of wine
consumption,12 13 the results of several other
studies do not show an advantage of one type of
alcoholic beverage over another.14 Studies have
suggested that the beneficial effects of wine
consumption compared with other beverages can
mainly be attributed to differences in socioeco-
nomic status, dietary and other lifestyle habits.15 16
In prospective cohort studies in which alcohol
intake is only assessed at the baseline examination,
consumption patterns are assumed to be relatively
constant over the entire study period. However, it
is unlikely that exposure measurements in the past
accurately reflect long-term alcohol intake as
consumption patterns usually change during life.
To get correct estimates of the long-term effects of
alcohol intake, repeated measures are needed.
Moreover, the use of repeated measures, especially
when using a cumulative average method, reduces
within-subject variation over time and, thereby,
misclassification in alcohol intake.17
In epidemiological studies, hazard ratios are
commonly used to express the impact on mortal-
ity. As hazard ratios express effects for an exposed
group relative to the effect of the unexposed group,
they do not provide information regarding absolute
health effects. Such insight can be obtained by the
calculation of life expectancies and the number of
life–years lost. Although concepts such as life
expectancy are more informative and easier to
understand, they are not reported frequently.
The objective of the present study is to assess
the relationship between long-term intake of
alcohol and the types of alcoholic beverages
consumed and cardiovascular and all-cause mortal-
ity. To obtain more accurate effect estimates, we
used seven repeated measures of the consumption
of alcoholic beverages. In addition to hazard ratios,
we also present our results in terms of differences
in life expectancy.
METHODS
Study population
The Zutphen Study has been carried out since 1960
among middle-aged men in Zutphen, an old
industrial town in the eastern part of The
Netherlands with about 30 000 inhabitants. In
1960, a random sample was drawn of 1088 men
born between 1900 and 1919 and living in Zutphen
for at least 5 years. Of those men, 878 participated
in the Zutphen Study (response rate 81%).
Examinations were repeated in 1965, 1970, 1985,
1990, 1995 and 2000. In 1985, the group of 554
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survivors was extended with a new random sample of men of
the same age. Of the 1266 men who were invited in 1985, 939
men participated (response rate 74%). In every examination
round, the participants who took part in both dietary and
physical examinations were selected for the present study (1373
men).
Baseline data were collected in 1960 before the Helsinki
Declaration was developed, and oral informed consent was
obtained in view of follow-up data. In 1985 and 1990, the study
was approved by the Medical Ethics Committee of the
University of Leiden, The Netherlands, and in 1995 and 2000,
by the Medical Ethics Committee of The Netherlands
Organisation for Applied Scientific Research (TNO).
Assessment of alcohol and food consumption
The habitual alcohol consumption was assessed as part of the
total diet, using the cross-check dietary history method,18
adapted to the Dutch situation.19 20 This method provides
information about the participant’s usual food and alcohol
consumption pattern, 6–12 months preceding the interview.
From 1985 onwards, the information about the usual food and
alcohol consumption pattern was limited to the month
preceding the interview because consumption patterns from
1985 were much more complicated than those in the 1960s. The
daily intake of alcohol, energy and other nutrients was
calculated using food composition tables close to the year of
measurement.21–23 Alcohol intake was highly reproducible
(r = 0.8),24 and ranking of the participants was considered valid,
as shown by the strong correlation with HDL cholesterol.25
To assess the relationship between different types of alcoholic
beverages and mortality, we calculated the alcohol intake from
wine, beer or spirits respectively. Participants were grouped into
three categories according to their intake of total alcohol and of
alcohol from beer, wine or spirits: 0, .0–20 and .20 g/day. As
studies have suggested that using non-drinkers as a reference
group is unsuitable for studying the effects of alcohol on
mortality because of the higher background risk among the
former drinkers,26–28 we created a time-dependent indicator
variable for those men who stopped drinking during follow-up.
Assessment of potential confounders
Detailed information on type and amount of smoking was
collected using standardised questionnaires. Cigarette, cigar or
pipe smokers were divided into categories of never or long-term
ex-smokers (ie, stopped smoking >10 years ago), recent ex-
smokers (ie, stopped smoking ,10 years ago) and current
smokers. Also, the number of years of cigarette smoking was
calculated. During physical examinations, the men’s weight and
height were measured and body mass index (BMI) was
calculated. Information about the prevalence and history of
clinical myocardial infarction (MI), stroke, diabetes mellitus
(DM) and cancer was collected throughout the study. The men
were classified into four levels of socioeconomic status (manual
workers, non-manual workers, small business owners and
professionals) according to occupation at baseline.
Case ascertainment
Participants were followed until death or censored on 30 June
2000. Three participants were lost to follow-up during the study
and were censored after their last physical examination.
Information about the causes of death was available from the
official death certificate, the medical history collected from
interviewing physicians or relatives of the dead person and other
witnesses, and from abstracts of hospital and other medical
records.29 The adjudication of the underlying causes of death
was done by one clinical epidemiologist (Dr Alessandro
Menotti, Association for Cardiac Research, Rome, Italy) and
coded according to the International Classification of Diseases,
8th Revision (codes 410–414 for coronary heart disease (CHD),
codes 430–438 for cerebrovascular diseases and codes 390–458
for CVD).30 Because the underlying cause of death in elderly
people is often difficult to ascertain, we included primary and
secondary causes of cardiovascular death.
Statistical analysis
Cox proportional hazard analyses with age as the time
variable31 32 were performed using the PHREG procedure of
SAS/STAT software (version 9.1; SAS Institute, Inc., Cary, NC,
USA). Time at entry was age on 31 December in the year
preceding the year in which the men participated in both
dietary and physical examinations for the first time, that is the
first measurement round; exit time was age at death, age when
lost to follow-up or age when censored, whichever came first.
We calculated the cumulative average alcohol intake to better
represent long-term intake. With this method, exposure
between 1960 and 1965 was calculated from the alcohol intake
from the 1960 examination round; exposure between 1965 and
1970 was calculated from the average alcohol intake from the
1960 and 1965 examination rounds, and so on.17 For those men
who were newly included in the study in 1985, information on
alcohol intake was missing in the period 1960–1970. To take
into account that average alcohol intake was higher in 1985
than in 1960–1970 and that taking cumulative averages
excluding earlier intakes in those men who were new to the
study in 1985 would overestimate their intake compared with
men included in 1960, multiple imputation,33 five times, of
alcohol intake and dietary covariates between 1960 and 1970
was carried out with an adapted version of predicted mean
matching.34 The SAS code that was used for the multiple
imputation can be downloaded from http://www.rivm.nl/
sasmacros. Analyses on long-term alcohol intake were per-
formed on five imputed datasets, and results were pooled using
the MIANALYZE procedure of SAS/STAT software.
The covariates in the multivariable models included an
indicator variable for former drinker, energy intake without
alcohol (kcal/day), consumption of vegetables (g/day), fruit (g/
day) and fish (g/day), intake of saturated and trans fatty acids
(g/day), BMI (kg/m2), cigar or pipe smoking (never and long-
term ex, recent-ex and current), cigarette smoking duration
(divided by 10 years), the daily number of cigarettes smoked
(divided by 10), prevalence of MI (yes or no), stroke (yes or no),
DM (yes or no) and cancer (yes or no), and indicator variables
for baseline socioeconomic status. In additional analyses, the
multivariable models for, respectively, alcohol from beer, wine
and spirits were additionally adjusted for total alcohol intake to
investigate the independent effects of alcohol from one specified
alcoholic beverage type. In the multivariable analyses, the
cumulative average intake of all dietary covariates was
calculated, and non-dietary covariates were updated at each
measurement round. To test the proportional hazards assump-
tion, a product term between alcohol intake and age was
included in the model, and a p-value for interaction ,0.10 was
considered statistically significant.
We determined differences in life expectancy at age 50, that is
average age at baseline, between men with different levels of
cumulative average alcohol intake, by calculating the area under
survival curves.35 To distinguish between the effects of alcohol
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intake and the effects of alcoholic beverage types, we compared
the life expectancies for men who consumed alcohol from wine
(.0 g/day) with those who consumed alcohol from beer and
spirits and those who consumed no alcohol from the specified
sources, using cumulative average intake at each measurement
round. The men were included in the analysis during the period
in which they met the requirements for the exposure categories
concerned. Cox models, with age as the time variable and
stratified by categories of amount (0, .0–20, .20 g/day) or
source (no alcohol, alcohol from wine, alcohol from beer or
spirits) of alcohol intake, were used to obtain the survival
curves. The Cox models were adjusted for baseline covariates,
that is dietary and smoking variables, BMI, prevalence of
chronic diseases (ie, MI, stroke, DM and cancer) and socio-
economic status. As several participants used more than one
type of alcoholic beverage in their usual diet and are, thereby,
included in different exposure categories at the same time, the
COVSANDWICH (AGGREGATE) statement was added to the
PHREG procedure. Areas under the survival curves from the five
imputed datasets were pooled,33 and 95% confidence intervals
were obtained using the bootstrap method.36
RESULTS
Population characteristics
During 40 years of follow-up (mean survival age 77 years), 1130
of the 1373 men participating in the present study died (table 1).
Of these deaths, 628 were cardiovascular disease (CVD) deaths,
348 were coronary heart disease (CHD) deaths and 139 were
cerebrovascular deaths.
The percentage of alcohol users almost doubled from 45% in
1960 to 86% in 2000 (table 1). Among users, average alcohol
consumption increased from 8 g/day in 1960 to 18 g/day among
the survivors in 1985, after which it decreased to 14 g/day in
2000 (table 1). The percentage of wine users increased
remarkably from 2% in 1960 to about 44% in 2000. This
increase was observed at all levels of socioeconomic status.
Among users, the average number of glasses consumed varied
between a half and 1.5 glasses per day for wine, beer and spirits.
With the exception of 1960, alcohol from spirits contributed the
most to the total alcohol intake (fig 1). The correlation between
alcohol from spirits and total alcohol intake varied between 0.67
and 0.86. For alcohol intake from wine and beer, the correlations
were lower.
Alcohol consumption, alcoholic beverages and mortality
Long-term alcohol intake was significantly and inversely
associated with mortality risk (table 2). Men with less than or
equal to 20 g of long-term (i.e. cumulative average) alcohol
intake had a 57% lower cerebrovascular mortality risk, a 30%
lower CVD mortality risk and a 25% lower all-cause mortality
risk compared with men with no alcohol intake. The associa-
tions for .20 g of long-term alcohol intake per day were
weaker than those for (20 g of long-term alcohol intake per
day.
In the next step, the independent effects of long-term alcohol
intake from wine, beer and spirits on mortality were estimated.
After additional adjustment for total alcohol intake, (20 g of
long-term alcohol intake from wine per day—compared with no
alcohol intake from wine—was inversely associated with CHD
(HR 0.61, 95% CI 0.41 to 0.89), CVD (HR 0.68, 95% CI 0.53 to
0.86) and all-cause mortality risk (HR 0.73, 95% CI 0.62 to 0.87;
table 3). In the models for CVD and all-cause mortality, (20 g
Table 1 Characteristics of men participating in the Zutphen Study by year of measurement*
Cohort 1960 1965 1970 1985 1990 1995 2000
No. of participants{ 1960 872 721 615 349 231 114 51
1985 476 306 161 68
Cumulative no of deaths
All causes – 40 103 412 645 889 1130
Total cardiovascular – 20 61 261 376 514 628
Coronary heart disease – 13 40 176 231 297 348
Cerebrovascular – 3 10 49 78 113 139
Age (years){ 49¡6 54¡5 59¡5 71¡5 75¡5 80¡4 83¡3
Body mass index (kg/m2) 24.1¡2.7 24.9¡2.7 25.2¡2.8 25.5¡3.1 25.5¡3.2 25.3¡3.4 26.0¡3.3
Overall smoking (%)1
Never and long-term ex 6 6 9 26 50 60 72
Recent-ex 6 11 15 31 17 16 14
Cigarettes 74 61 53 30 23 18 6
Cigars or pipes 14 21 23 13 10 6 8
Energy without alcohol (kcal) 3082¡673 2920¡674 2539¡539 2146¡506 2029¡458 2029¡468 1991¡457
Alcohol intake (g/day)" 1960 8¡13 10¡13 12¡13 18¡19 14¡15 14¡14 13¡11
1985 – – – 18¡17 14¡14 13¡15 14¡16
Alcohol users (%) 1960 45 62 72 75 78 80 86
1985 – – – 75 72 78 85
Beer users (%) 1960 38 35 42 24 22 22 37
1985 – – – 24 25 25 29
Wine users (%) 1960 2 5 6 20 26 29 39
1985 – – – 25 31 38 47
Spirits users (%) 1960 15 42 52 55 55 58 61
1985 – – – 55 49 49 54
*Numbers represent means ¡ standard deviation, unless indicated otherwise.
{In every measurement round, the participants who took part in both physical and dietary examinations were selected for the analyses.
{Age is defined as age on 31 December in the year preceding the examination.
1Never and long-term ex-smokers are defined as men who never smoked or stopped smoking >10 years ago; recent ex-smokers are defined as men who stopped smoking
,10 years ago.
"Average alcohol intake was calculated among alcohol users.
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of long-term total alcohol intake remained inversely associated
with mortality (HR CVD mortality 0.76, 95% CI 0.59 to 0.97;
HR all-cause mortality 0.80, 95% CI 0.67 to 0.97). Additional
analyses showed that the inverse association between wine
consumption and mortality was present in all socioeconomic
classes. Among manual workers, the HRs for long-term wine
consumption were 0.63 (95% CI 0.31 to 1.30) for CHD, 0.78
(95% CI 0.49 to 1.23) for CVD and 0.78 (95% CI 0.54 to 1.12)
for all-cause mortality. Among the professionals, the hazard
ratios were comparable.
Long-term consumption of alcohol from beer and spirits was
not independently related to mortality (table 3). However,
given the strong correlation between alcohol from spirits and
total alcohol intake, these findings should be interpreted with
caution. Omitting the adjustment for the prevalence of chronic
diseases changed our results slightly, but the overall conclusions
remained the same.
Alcohol consumption, alcoholic beverages and life expectancy
Men with a long-term alcohol intake (20 g/day (on average
6 g/day) had a 2.3 year (95% CI 0.5 to 4.2 years) longer life
expectancy at age 50 compared with those who consumed no
alcohol. For those men who consumed more than 20 g of
alcohol per day (on average 29 g/day), life expectancy was
1.9 years (21.1 to 4.9 years) longer compared with non-users.
Men who consumed alcohol from wine, on average 2 g/day,
over a longer time period had a 2.5 years longer life expectancy
at age 50 (20.3 to 5.3 years) compared with those who
consumed alcohol from beer or spirits (on average about 8 g/
day; fig 2) and a 4.7 years (1.6 to 7.7 years) longer life
expectancy compared with no alcohol users.
DISCUSSION
Long-term light alcohol intake lowered cerebrovascular, total
CVD and all-cause mortality risk, and was associated with a
longer life expectancy compared with no alcohol intake.
Independent of total alcohol intake, wine consumption was
strongly and inversely associated with CHD, total CVD and all-
cause mortality. For long-term wine consumers, consuming on
average less than half a glass of wine per day, life expectancy at
age 50 was about 5 years longer compared with no alcohol
users.
The major strength of this study was the collection of
detailed information on the consumption of different alcoholic
beverages at each of seven examination rounds during 40 years
of follow-up. This enabled us to study the effects of long-term,
that is cumulative average, alcohol intake on mortality. The use
of cumulative average intakes reduces within-subject variation
over time and, thereby, measurement error. The detailed
information on potential confounders such as smoking,37–39
diet40 and socioeconomic status41 made it possible to study the
independent effect of total alcohol intake and alcohol from
different types of alcoholic beverages.
The present study also has some weaknesses. First, recent
studies have observed that, among men, frequency of alcohol
consumption was inversely associated with coronary heart
disease risk, independent of the amount of alcohol consumed.42–44
As information on alcohol consumption in the present study was
collected as part of the usual diet, no data were available on
drinking frequency. Second, average long-term alcohol intake in
the present study was relatively low, and most participants used
more than one type of alcoholic beverage in their usual diet. This
may have led to less precise estimations of the effect of different
types of alcoholic beverages on mortality. Third, for those men
who were newly included in the study in 1985, information on
alcohol intake was missing for the period 1960–1970. By multiple
imputations of total alcohol intake, different types of alcoholic
beverages and other dietary covariates in 1960–1970, we were
able to counter an underestimation of cumulative average
intake from 1985 onwards for those men who were newly
included in the study. We repeated our analysis among the
participants who were included in the study from 1960
(n = 875) and found similar associations between long-term
total alcohol intake and different types of alcoholic beverages
and mortality. Therefore, it is unlikely that the imputation of
total alcohol intake, different types of alcoholic beverages and
Figure 1 The contribution of alcohol from beer, wine and spirits to total
alcohol intake within the Zutphen Study during 40 years of follow-up.
Table 2 Long-term alcohol consumption in relation to cardiovascular
and all-cause mortality within the Zutphen Study
Amount
(g/day)
Long-term intake (cumulative average, time-
dependent)
Crude HR
(95% CI)*
Adjusted HR
(95% CI){{
Coronary heart disease .0 to 20 0.92 (0.67 to 1.25) 0.80 (0.57 to 1.11)
.20 0.80 (0.49 to 1.31) 0.77 (0.44 to 1.33)
Cerebrovascular .0 to 20 0.44 (0.28 to 0.68) 0.43 (0.26 to 0.70)
.20 0.44 (0.22 to 0.92) 0.56 (0.25 to 1.25)
Total cardiovascular .0 to 20 0.75 (0.60 to 0.95) 0.70 (0.55 to 0.89)
.20 0.78 (0.56 to 1.10) 0.83 (0.56 to 1.22)
All cause .0 to 20 0.78 (0.65 to 0.93) 0.75 (0.63 to 0.91)
.20 0.82 (0.63 to 1.07) 0.82 (0.61 to 1.12)
*Crude HR, hazard ratio; CI, confidence interval.
{Hazard ratios are adjusted for former drinking, energy intake without alcohol, the
number of cigarettes smoked, cigarette smoking duration, cigar or pipe smoking,
intake of vegetables, fruit, fish, saturated fat and trans fatty acids, body mass index,
prevalence of myocardial infarction, stroke, diabetes mellitus and cancer, and baseline
socioeconomic status.
{Because of missing data in the covariates, the number of events is less than the
number mentioned in table 1.
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other dietary covariates among those men who were newly
included in the study from 1985 biased our results.
Our results confirm the inverse association between moderate
alcohol intake, CVD and all-cause mortality risk observed in other
studies.38 39 45–53 In contrast to these and other studies,38 39 45 53–56
the highest exposure level was not associated with an increased
mortality risk. However, average alcohol intake in the highest
exposure level was relatively low (29 g/day) in the Zutphen
Study, which may explain the lack of a positive association
between mortality and a higher intake level. In their meta-
analysis, Corrao et al estimated that the risk of CHD mortality is
lowest at 16 g/day with a corresponding hazard ratio of 0.84.57 In
the present study, the hazard ratios for CHD mortality were
comparable but not statistically significant (table 2).
Smoking might confound the association between alcohol
intake and mortality. Previous results from the Zutphen Study
indicated that the number of cigarettes smoked as well as the
duration of cigarette smoking are, independently of each other,
associated with mortality.58 In our multivariable analyses, we
adjusted for these aspects of smoking. So, it is not likely that the
association between alcohol intake and mortality is explained
by confounding due to smoking.
In the present study, wine consumption was associated with
a lower mortality risk, independent of total alcohol intake.
Some studies did not demonstrate a favourable effect of one
specific type of alcoholic beverage over another,14 42 while others
found an inverse and independent association between wine
consumption and mortality.13 59–61 In the present study, 70% of
all wine consumed was red wine. This suggests that the
cardioprotective effect of wine could be due to a protective
effect of polyphenolic compounds in red wine, but other
explanations cannot be ruled out.
Table 3 Long-term consumption of alcohol from beer, wine or spirits in relation to cardiovascular and all-cause mortality within the Zutphen Study
Alcohol source Amount (g/day)
Long-term intake (cumulative average, time-dependent)
Crude HR (95% CI)* Adjusted HR (95% CI){1 Adjusted HR (95% CI){1
Coronary heart disease Wine .0 to 20 0.59 (0.42 to 0.83) 0.60 (0.41 to 0.87) 0.61 (0.41 to 0.89)
.20 NI" NI NI
Beer .0 to 20 0.86 (0.68 to 1.09) 0.79 (0.62 to 1.02) 0.82 (0.60 to 1.12)
.20 1.13 (0.41 to 3.08) 1.02 (0.35 to 2.93) 1.10 (0.36 to 3.39)
Spirits .0 to 20 0.93 (0.70 to 1.23) 0.85 (0.63 to 1.15) 0.92 (0.63 to 1.34)
.20 0.86 (0.40 to 1.84) 0.89 (0.42 to 1.86) 1.01 (0.35 to 2.97)
Cerebrovascular Wine .0 to 20 0.67 (0.44 to 1.01) 0.82 (0.53 to 1.26) 0.92 (0.58 to 1.46)
.20 NI NI NI
Beer .0 to 20 0.64 (0.45 to 0.93) 0.62 (0.42 to 0.92) 0.81 (0.48 to 1.35)
.20 0.68 (0.09 to 5.01) 0.78 (0.10 to 6.26) 0.78 (0.09 to 6.73)
Spirits .0 to 20 0.76 (0.51 to 1.13) 0.79 (0.52 to 1.20) 1.44 (0.72 to 2.86)
.20 0.62 (0.19 to 1.97) 0.70 (0.21 to 2.34) 0.93 (0.20 to 4.32)
Total cardiovascular Wine .0 to 20 0.63 (0.51 to 0.78) 0.66 (0.52 to 0.84) 0.68 (0.53 to 0.86)
.20 1.37 (0.19 to 9.78) 2.45 (0.33 to 18.1) 2.20 (0.30 to 16.4)
Beer .0 to 20 0.84 (0.70 to 1.00) 0.82 (0.69 to 0.99) 0.91 (0.72 to 1.14)
.20 1.30 (0.62 to 2.74) 1.29 (0.58 to 2.84) 1.26 (0.55 to 2.88)
Spirits .0 to 20 0.85 (0.69 to 1.04) 0.82 (0.66 to 1.03) 0.93 (0.70 to 1.24)
.20 0.84 (0.50 to 1.41) 0.91 (0.54 to 1.55) 0.88 (0.47 to 1.64)
All-cause Wine .0 to 20 0.68 (0.58 to 0.78) 0.72 (0.61 to 0.85) 0.73 (0.62 to 0.87)
.20 0.79 (0.11 to 5.59) 1.28 (0.18 to 9.28) 1.21 (0.17 to 8.82)
Beer .0 to 20 0.91 (0.80 to 1.05) 0.89 (0.78 to 1.02) 0.98 (0.83 to 1.17)
.20 1.41 (0.84 to 2.36) 1.29 (0.76 to 2.19) 1.37 (0.74 to 2.53)
Spirits .0 to 20 0.86 (0.75 to 1.00) 0.87 (0.74 to 1.01) 0.97 (0.80 to 1.18)
.20 1.08 (0.76 to 1.53) 1.02 (0.67 to 1.55) 1.09 (0.69 to 1.73)
*Crude HR, hazard ratio; CI, confidence interval.
{Hazard ratios are adjusted for former drinking, energy intake without alcohol, the number of cigarettes smoked, cigarette smoking duration, cigar or pipe smoking, intake of
vegetables, fruit, fish, saturated and trans fatty acids, body mass index, prevalence of myocardial infarction, stroke, diabetes mellitus and cancer, and baseline socioeconomic
status.
{Hazard ratios are adjusted for former drinking, energy intake without alcohol, the number of cigarettes smoked, cigarette smoking duration, cigar or pipe smoking, intake of
vegetables, fruit, fish, saturated and trans fatty acids, body mass index, prevalence of myocardial infarction, stroke, diabetes mellitus and cancer, baseline socioeconomic status and
total alcohol intake.
1Because of missing data in the covariates, the number of events may be smaller than the number mentioned in table 1.
"NI, because of the small number of men with .20 g of long-term alcohol intake from wine, the calculated hazard ratios are not informative.
Figure 2 Survival curves for men with long-term consumption of
alcohol from wine, beer or spirits, and no alcohol consumers within the
Zutphen Study, adjusted for baseline energy intake without energy from
alcohol, the number of cigarettes smoked, cigar or pipe smoking, intake
of vegetables, fruit, fish, saturated and trans fatty acids, body mass
index, prevalence of myocardial infarction, stroke, cancer and diabetes
mellitus, and socioeconomic status.
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Socioeconomic status might confound the association
between wine consumption and mortality. However, in our
multivariable analyses, we adjusted for socioeconomic status,
based on occupation at baseline. At the start of the present
study, the men were already in a later phase in their careers, and
baseline socioeconomic status was considered to be a good
indicator during the follow-up period. Furthermore, the increase
in the percentage of wine users during follow-up was observed
at all levels of socioeconomic status, and additional stratified
analyses showed that the inverse association between wine
consumption and mortality was present in all socioeconomic
classes. These results suggest that the association between wine
consumption and mortality cannot be explained by confound-
ing due to socioeconomic status.
Long-term wine consumers had about 5 years longer life
expectancy at age 50 compared with no alcohol users. Of these
5 years, about 2 years can be attributed to an effect of alcohol
intake and is in accordance with the inverse association between
long-term alcohol intake and all-cause mortality found in the
present study. The remaining 3 years can be attributed to an
effect of wine consumption. However, given the wide confidence
interval, the effect of wine as such may be overestimated. To our
knowledge, we are the first to study the effects of absolute
alcohol intake and type of alcoholic beverage on life expectancy,
and more studies are needed to verify our results.
In conclusion, long-term light alcohol intake is associated
with a lower risk of cardiovascular and all-cause mortality risk
and a longer life expectancy. The inverse associations between
wine consumption and mortality remained after adjustment for
total alcohol intake. Wine consumers had a 5 years longer life
expectancy compared with no alcohol consumers; however,
more studies are needed to draw conclusions on the strength of
the association between wine consumption and mortality.
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